XML 33 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities:    
Net loss $ (853) $ (6,265)
Non-cash items in net loss:    
Depreciation and amortization 7,792 2,696
Amortization of debt issuance costs 320 116
Employee stock-based compensation costs 1,991 1,229
Noncash lease costs 782 (4,385)
Changes in deferred taxes (887) (1,103)
Changes in operating assets and liabilities:    
Receivables (2,947) (113)
Prepaid and other current assets 179 (1,004)
Deferred costs and other assets (330) (856)
Accounts payable 562 5,989
Deferred revenue 1,135 (212)
Earn-out payment   (385)
Accrued and other liabilities (3,337) 3,876
Net cash provided by (used in) operating activities 4,407 (417)
Investing activities:    
Purchases of property, equipment and internal-use software (5,007) (1,742)
Acquisition of business, net of cash acquired   (271,706)
Net cash used in investing activities (5,007) (273,448)
Financing activities:    
Proceeds of long-term debt 6,000 175,000
Debt issuance cost   (6,389)
Proceeds from exercise of stock options 117 36
Repayment of long-term debt (460)  
Repayment of finance lease liabilities (406)  
Purchase of treasury shares (1,785) (1,340)
Earn-out payment   (415)
Net cash provided by financing activities 3,466 263,480
Effect of exchange rate on cash 80 (33)
Increase (decrease) in cash and cash equivalents 2,946 (10,418)
Cash and cash equivalents, beginning of period 13,349 27,109
Cash and cash equivalents, end of period $ 16,295 16,691
Series A Convertible Preferred Stock [Member]    
Financing activities:    
Proceeds from issuance of preferred stock, net of offering costs   62,692
Series B Convertible Preferred Stock [Member]    
Financing activities:    
Proceeds from issuance of preferred stock, net of offering costs   $ 33,896